Known targets — ChEMBL curated mechanism
ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3BCHECHRM1CHRM2CHRM3CHRM4CHRNA3CHRNA4CHRNB2CHRNB4ESR1ESR2GABRA1GABRB1GABRG2GBA1GHSRHRH1HTR1DHTR2AMAOBOPRD1OPRK1OPRM1SLC6A2SLC6A3TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8UGCGrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Cadaverine Tartrate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 known ✓ | P08172 | 1/20 | 0.32 |
| ▸ | CHRM1 known ✓ | P11229 | 1/20 | 0.32 |
| ▸ | CHRM3 known ✓ | P20309 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 6/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.44 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 3/20 | 0.36 |
| ▸ | KCNA1 | Q09470 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | PDE4A | P27815 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cadaverine Tartrate SCHEMBL5874349 | 0.93 | TSHR (0.42) | TSHRCYP3A4PMP22LMNATDP1 | |
| Tetrapropylammonium SCHEMBL5874101 | 0.83 | TSHR (0.42) | TSHRCYP3A4PMP22LMNATDP1 | |
| Cadaverine Tartrate SCHEMBL3810388 | 0.80 | TSHR (0.56) | TSHRCYP3A4PMP22LMNATDP1 | |
| Tetrabuthylammonium SCHEMBL5874528 | 0.79 | SLC22A1 (0.46) | TSHRCYP3A4PMP22LMNATDP1 | |
| Tetrylammonium SCHEMBL36648 | 0.78 | TSHR (0.42) | TSHRCYP3A4PMP22NFKB1KCNA1 | |
| Tetrylammonium SCHEMBL5874502 | 0.77 | TSHR (0.36) | TSHRCYP3A4PMP22TDP1NFKB1 | |
| Cadaverine Tartrate SCHEMBL3209520 | 0.77 | TSHR (0.67) | TSHRCYP3A4PMP22LMNATDP1 | |
| Cadaverine Tartrate SCHEMBL21569383 | 0.77 | TSHR (0.67) | TSHRCYP3A4PMP22LMNATDP1 | |
| Cadaverine Tartrate SCHEMBL7510054 | 0.77 | TSHR (0.67) | TSHRCYP3A4PMP22LMNATDP1 | |
| Cadaverine Tartrate SCHEMBL21569402 | 0.77 | TSHR (0.67) | TSHRCYP3A4PMP22LMNATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119684381-A | Crystalline forms of nicotinamide riboside furanoside salts and nutritional supplements and pharmaceutical compositions containing same | 生物合成股份公司 | 2025-03-25 | — | — | CN | disclosed |
| CN-119462782-A | Method for producing nicotinamide riboside salts, nicotinamide riboside salts per se and use thereof | 生物合成股份公司 | 2025-02-18 | — | — | CN | disclosed |
| US-11485915-B2 | Methods of using ionic liquids as corrosion inhibitors | BAKER HUGHES HOLDINGS LLC (US) | 2022-11-01 | — | — | US | disclosed |
| CN-114423771-A | Method for producing nicotinamide ribofuranoside salts, nicotinamide ribofuranoside salts themselves and use thereof | 生物合成股份公司 | 2022-04-29 | — | — | CN | disclosed |
| US-20220098494-A1 | METHODS OF USING IONIC LIQUIDS AS CORROSION INHIBITORS | BAKER HUGHES HOLDINGS LLC | 2022-03-31 | — | — | US | disclosed |
| US-7128976-B2 | Composition for film formation, method of film formation, and silica-based film | JSR CORPORATION (JP) | 2006-10-31 | — | — | US | disclosed |
| US-20030091838-A1 | Composition for film formation, method of film formation, and silica-based film | JSR CORPORATION (JP) | 2003-05-15 | — | — | US | disclosed |